文献速递垂体与肾上腺疾病

非先天性肾上腺皮质增生性原发性肾上腺功能不全患儿的类固醇激素谱与分子诊断工具

Steroid Hormone Profiles and Molecular Diagnostic Tools in Pediatric Patients With non-CAH Primary Adrenal Insufficiency.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

该研究纳入18家儿童内分泌诊所的41例病因不明的非先天性肾上腺皮质增生性原发性肾上腺功能不全患儿,采用靶向基因 panel 测序(TPS)和全外显子测序(WES)进行遗传分析,并用液相色谱-质谱法量化血浆肾上腺类固醇。TPS在29例(70.7%)患儿中获得遗传学诊断,WES未提供额外分子诊断;与健康对照组相比,患儿类固醇浓度更低,以可的松、皮质醇和皮质酮最为显著(P < .0001,曲线下面积分别为.96、.88和.87)。

要点

  • TPS在29例(70.7%)病因不明的非CAH PAI患儿中获得遗传学诊断,WES未提供额外诊断。
  • 患儿可的松、皮质醇和皮质酮浓度低于健康对照组(P < .0001)。
  • 血浆皮质醇低于4 ng/mL、可的松低于11 ng/mL、皮质酮低于0.11 ng/mL对诊断该病具有大于95%的特异性。

核心结论

  • 类固醇激素谱对病因不明的非CAH PAI诊断高度敏感,但不太可能指向特定分子诊断。
  • TPS是这些患者分子诊断的最佳方法且高效,而WES预期额外获益很少。

研究设计与样本

  • 研究纳入18家儿童内分泌诊所的41例病因不明的非CAH PAI患儿(17例女孩,中位年龄3个月,范围0-8岁)。
  • 采用靶向基因panel测序(TPS)和全外显子测序(WES)进行遗传分析,并用液相色谱-质谱法量化血浆肾上腺类固醇并与对照组比较。

主要发现

  • TPS在29例(70.7%)患者中获得遗传学诊断,WES未能进一步获得分子诊断。
  • 与健康对照组相比,患者类固醇浓度更低,以可的松、皮质醇和皮质酮最具统计学显著性(P < .0001,受试者工作特征曲线下面积分别为.96、.88和.87)。
  • 血浆皮质醇低于4 ng/mL、可的松低于11 ng/mL和皮质酮低于0.11 ng/mL对确保病因不明的非CAH PAI诊断具有大于95%的特异性。

关键数值与推荐

  • 血浆皮质醇低于4 ng/mL对确保病因不明的非CAH PAI诊断具有大于95%的特异性。
  • 血浆可的松低于11 ng/mL对确保病因不明的非CAH PAI诊断具有大于95%的特异性。
  • 血浆皮质酮低于0.11 ng/mL对确保病因不明的非CAH PAI诊断具有大于95%的特异性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: There is a significant challenge of attributing specific diagnoses to patients with primary adrenal insufficiency of unknown etiology other than congenital adrenal hyperplasia (non-CAH PAI). Specific diagnoses per se may guide personalized treatment or may illuminate pathophysiology. OBJECTIVE: This work aimed to investigate the efficacy of steroid hormone profiles and high-throughput sequencing methods in establishing the etiology in non-CAH PAI of unknown origin. METHODS: Pediatric patients with non-CAH PAI whose etiology could not be established by clinical and biochemical characteristics were enrolled. Genetic analysis was performed using targeted-gene panel sequencing (TPS) and whole-exome sequencing (WES). Plasma adrenal steroids were quantified by liquid chromatography-mass spectrometry and compared to that of controls. This study comprised 18 pediatric endocrinology clinics with 41 patients (17 girls, median age: 3 mo, range: 0-8 y) with non-CAH PAI of unknown etiology. RESULTS: A genetic diagnosis was obtained in 29 (70.7%) patients by TPS. Further molecular diagnosis could not be achieved by WES. Compared to a healthy control group, patients showed lower steroid concentrations, most statistically significantly in cortisone, cortisol, and corticosterone (P < .0001, area under the receiver operating characteristic curve: .96, .88, and .87, respectively). Plasma cortisol of less than 4 ng/mL, cortisone of less than 11 ng/mL, and corticosterone of less than 0.11 ng/mL had a greater than 95% specificity to ensure the diagnosis of non-CAH PAI of unknown etiology. CONCLUSION: Steroid hormone profiles are highly sensitive for the diagnosis of non-CAH PAI of unknown etiology, but they are unlikely to point to a specific molecular diagnosis. TPS is an optimal approach in the molecular diagnosis of these patients with high efficacy, whereas little additional benefit is expected from WES.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Seven Menevse T, Kendir Demirkol Y, Gurpinar Tosun B, et al. Steroid Hormone Profiles and Molecular Diagnostic Tools in Pediatric Patients With non-CAH Primary Adrenal Insufficiency. J Clin Endocrinol Metab. 2022. PMID: 35028661. doi:10.1210/clinem/dgac016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。